CELA2A
Chymotrypsin-like elastase family member 2A
Also known as: CEL2A_HUMAN, ELA2A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P08217
- Gene
- CELA2A
- Ensembl
- ENSG00000142615
- Chromosome
- 1
- Canonical length
- 269 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins
- Secretome location
- Secreted to digestive system
OverviewNCBI Gene
Elastases form a subfamily of serine proteases that hydrolyze many proteins in addition to elastin. Humans have six elastase genes which encode the structurally similar proteins elastase 1, 2, 2A, 2B, 3A, and 3B. Like most of the human elastases, elastase 2A is secreted from the pancreas as a zymogen. In other species, elastase 2A has been shown to preferentially cleave proteins after leucine, methionine, and phenylalanine residues. [provided by RefSeq, May 2009]
Canonical amino-acid sequenceUniProt
269 residues, UniProt reviewed canonical sequence.
>P08217|CELA2A
1 MIRTLLLSTL VAGALSCGDP TYPPYVTRVV GGEEARPNSW PWQVSLQYSS NGKWYHTCGG
61 SLIANSWVLT AAHCISSSRT YRVGLGRHNL YVAESGSLAV SVSKIVVHKD WNSNQISKGN
121 DIALLKLANP VSLTDKIQLA CLPPAGTILP NNYPCYVTGW GRLQTNGAVP DVLQQGRLLV
181 VDYATCSSSA WWGSSVKTSM ICAGGDGVIS SCNGDSGGPL NCQASDGRWQ VHGIVSFGSR
241 LGCNYYHKPS VFTRVSNYID WINSVIANNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CELA2A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 153,460 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 153,460 nTPM
- ovary: 28 nTPM
- salivary gland: 26 nTPM
- heart muscle: 25 nTPM
- duodenum: 17 nTPM
- stomach: 15 nTPM
Single-cell type
- pancreatic acinar cells: 1,882 nCPM
- pancreatic duct cells: 15 nCPM
- epicardial cells: 9.1 nCPM
- basal keratinocytes: 4.9 nCPM
- monocytes: 3.7 nCPM
- endometrial luminal cells: 3.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 1.1 nTPM
- cerebral cortex: 0.9 nTPM
- basal ganglia: 0.8 nTPM
- midbrain: 0.6 nTPM
- thalamus: 0.6 nTPM
- hippocampal formation: 0.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CELA2A.
Disease | AllUniProt
Conditions CELA2A is implicated in, by any mechanism.
- Abdominal obesity-metabolic syndrome 4 (AOMS4) MIM:618620
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 56 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Abdominal obesity-metabolic syndrome 4
- Coronary artery disorder
- Hypertriglyceridemia
- Diabetes
- Hypertensive disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.83
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.04
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- insulin catabolic process
- proteolysis
- regulation of insulin secretion
- regulation of platelet aggregation
- response to insulin
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CELA2A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CELA2A as an antibody target. Whether an autoantibody or antibody against CELA2A could matter depends on whether native CELA2A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CELA2A is annotated as secreted, so native CELA2A circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CELA2A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...